Claris collects $118M to take eye drop into pivotal testing next year
Claris Bio has a fresh CEO, new board chair and $118 million for two pivotal trials to see if its eye drop can succeed in a blinding disease with no pharmaceutical treatment options. It's a ...
Claris CEO Stephen Brady July 28, 2026 08:00 AM EDT FinancingStartups Claris collects $118M to take eye drop into pivotal testing next year Kyle LaHucik Biotech Correspondent Claris Bio has a fresh CEO, new board chair and $118 million for two pivotal trials to see if its eye drop can succeed in … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER
comments(0)
5-min edit window · permanent after that